Surgery Grand Rounds

“The Journey of Engineering Human Blood Vessels for People

Science, Translation and Clinical Development”

Wednesday, December 11, 2019 Duke North – 2002

7:00 am – 8:00 am

Jeffrey H. Lawson, M.D., Ph.D.

President and Chief Executive Officer

Humacyte Incorporated

Adjunct Professor of Surgery

Division of Vascular and Endovascular Surgery

Duke Department of Surgery

Moderator:  Allan D. Kirk, M.D., Ph.D., FACS

Disclosures: 

Dr. Kirk:  MedBlue Data (stockholder, other), Semma Therapeutics (Advisory Board), MedBlue (Other), BMS (PI)

Dr. Lawson:  Humacyte (Employee, stockholder), InnAVasc (Stockholder)